Ipamorelin/CJC-1295 No DAC
Ipamorelin and CJC-1295 without DAC Blend
Description
A powerful synergistic combination of growth hormone secretagogues. Ipamorelin provides selective GH release while CJC-1295 extends GH pulse duration for enhanced fat loss and recovery.
Overview
The combination of CJC-1295 (no DAC) and Ipamorelin produces synergistic increases in GH and IGF-1. Clinicians report improvements in fat loss, lean mass preservation, energy, and deep-wave sleep.
Mechanism of Action
CJC-1295 (no DAC) is a GHRH analogue that stimulates the pituitary to release endogenous GH and increases IGF-1. Ipamorelin is a GHRP. When administered together they have synergistic effects on GH with minimal impact on ghrelin, prolactin, ACTH, or cortisol.
Benefits
- •Enhanced fat loss
- •Muscle preservation
- •Improved sleep
- •Anti-aging benefits
Dosing Notes
Common protocols: 0.05-0.1 mL SQ at bedtime, 5 days/week, on an empty stomach 2-3 hours after the last meal.
Reported Side Effects
- •One myocardial infarction death reported in the CJC-1295 DAC Phase II trial, attributed by the attending physician to pre-existing asymptomatic coronary disease and considered unrelated to treatment.
Safety Notes
GH may be mitogenic; caution in patients with cancer or cancer risk. GH can mask hypothyroid symptoms - monitor thyroid panel. CJC-1295 and CJC-1295 w/DAC are banned by WADA.
Commonly Stacked With
Scientific References
Related Weight Loss Peptides
Tesofensine
Tesofensine
A serotonin-norepinephrine-dopamine reuptake inhibitor originally studied as an anti-obesity agent. Promotes weight loss through appetite suppression.
0.25-1 mgAOD-9604
Anti-Obesity Drug 9604
A synthetic peptide analog of natural AOD-9604 fragment that stimulates lipolysis and inhibits lipogenesis without affecting IGF-1 or insulin.
300 mcg5-Amino-1MQ
5-Amino-1-Methylquinolinium
A small molecule that inhibits NNMT enzyme, boosting NAD+ levels and cellular energy. Supports fat loss and metabolic function.
1 mgTriple Threat Blend
NAD+, MOTS-c, and 5-Amino-1MQ Blend
A synergistic combination targeting mitochondrial function, cellular energy, and fat metabolism. Combines NAD+ precursor with mitochondrial peptide and NNMT inhibitor for comprehensive metabolic support.
10 mg/1mg/1mg